Sleep apnea syndrome.
Sleep apnea syndrome is estimated to affect as many as 2 to 3 percent of the adult male population. Excessive snoring and daytime sleepiness are but a few of the many clues to diagnosis. The hypoxemia occurring as a result of apnea may lead to pulmonary hypertension. Depressed respiratory center neural output or upper airway occlusion during sleep may cause the apnea. There are a number of treatment options available.
D000086:Acetazolamide / Q000627:therapeutic use; D000328:Adult; D003937:Diagnosis, Differential; D004562:Electrocardiography; D004569:Electroencephalography; D004585:Electrooculography; D006801:Humans; D008297:Male; D009290:Narcolepsy / Q000175:diagnosis; D010102:Oxygen Inhalation Therapy; D010159:Palate / Q000601:surgery; D010614:Pharynx / Q000503:physiopathology / Q000601:surgery; D011175:Positive-Pressure Respiration; D011374:Progesterone / Q000627:therapeutic use; D011530:Protriptyline / Q000627:therapeutic use; D012890:Sleep / Q000502:physiology; D012891:Sleep Apnea Syndromes / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D012893:Sleep Wake Disorders / Q000209:etiology; D012895:Sleep, REM; D013806:Theophylline / Q000627:therapeutic use; D014140:Tracheotomy; D014609:Uvula / Q000601:surgery
D011374:Progesterone; D011530:Protriptyline; D013806:Theophylline; D000086:Acetazolamide